{"id":8380,"date":"2020-07-21T15:51:50","date_gmt":"2020-07-21T22:51:50","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=8380"},"modified":"2021-04-02T15:52:32","modified_gmt":"2021-04-02T22:52:32","slug":"seroprevalence-of-antibodies-to-sars-cov-2-in-10-sites-in-the-united-states-march-23-may-12-2020","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/07\/21\/seroprevalence-of-antibodies-to-sars-cov-2-in-10-sites-in-the-united-states-march-23-may-12-2020\/","title":{"rendered":"Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"47\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Havers et al. report<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">a cross-sectional sero<\/span><span data-contrast=\"auto\">prevalence\u00a0<\/span><span data-contrast=\"auto\">survey conducted on a convenience sample of residual sera collected from March 23 through May 12 for routine clinical testing in San Francisco (SF), Connecticut (CT), south Florida (SF), Louisiana (LA), Minneapolis-St Paul-St Cloud metro area (MN), Missouri (MS), New York City Metro Area (NYC), Philadelphia metro area (PA), Utah (UT), and western Washington state (WA) (n=16,025 individuals). Seropositivity ranged from 1% in SF (late April) to\u00a0<\/span><span data-contrast=\"auto\">7<\/span><span data-contrast=\"auto\">% in NYC (late March\/early April)<\/span><span data-contrast=\"auto\">.\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"47\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">The e<\/span><span data-contrast=\"auto\">stimated number of infections ranged from 6<\/span><span data-contrast=\"auto\">&#8211;<\/span><span data-contrast=\"auto\">\u00a0to\u00a0<\/span><span data-contrast=\"auto\">24<\/span><span data-contrast=\"auto\">&#8211;<\/span><span data-contrast=\"auto\">times the number of\u00a0reported cases.\u00a0<\/span><i><span data-contrast=\"auto\">[<\/span><\/i><i><span data-contrast=\"auto\">EDITORIAL NOTE<\/span><\/i><i><span data-contrast=\"auto\">: Seropositivity in individuals undergoing routine clinical testing may not reflect\u00a0<\/span><\/i><i><span data-contrast=\"auto\">seropositivity in the general population.<\/span><\/i><i><span data-contrast=\"auto\">\u00a0A version of these findings was published as a pre-print article that was included in this Literature Report on June 2<\/span><\/i><i><span data-contrast=\"auto\">9, 2020<\/span><\/i><i><span data-contrast=\"auto\">]<\/span><\/i><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Havers et al. (July 21, 2020). Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Internal Medicine.\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1001\/jamainternmed.2020.4130\"><i><span data-contrast=\"none\">https:\/\/doi.org\/10.1001\/jamainternmed.2020.4130<\/span><\/i><\/a><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Havers et al. report\u00a0a cross-sectional seroprevalence\u00a0survey conducted on a convenience sample of residual sera collected from March 23 through May 12 for routine clinical testing in San Francisco (SF), Connecticut (CT), south Florida (SF), Louisiana (LA), Minneapolis-St Paul-St Cloud metro area (MN), Missouri (MS), New York City Metro Area (NYC), Philadelphia metro area (PA), Utah&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/07\/21\/seroprevalence-of-antibodies-to-sars-cov-2-in-10-sites-in-the-united-states-march-23-may-12-2020\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[21],"class_list":["post-8380","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-transmission"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=8380"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8380\/revisions"}],"predecessor-version":[{"id":8381,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8380\/revisions\/8381"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=8380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=8380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=8380"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=8380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}